Puma Biotechnology reported $16.44M in Equity Capital and Reserves for its first fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Acceleron Pharma XLRN:US $ 810.83M 44.28M
Agios Pharmaceuticals AGIO:US $ 2296.63M 1897.13M
Alexion Pharmaceuticals ALXN:US $ 12416.8M 765.6M
Alnylam Pharmaceuticals ALNY:US $ 926.19M 90.06M
Amgen AMGN:US $ 9334M 75M
Arena Pharmaceuticals ARNA:US $ 1085.99M 5.52M
Array Technologies Inc ARRY:US -70115000 10.78M
Biogen BIIB:US $ 10751.9M 69.7M
Biomarin Pharmaceutical BMRN:US $ 4162.01M 56.01M
Bluebird Bio BLUE:US $ 1200.33M 154.72M
Clovis Oncology CLVS:US $ -221.04M 62.29M
Daiichi Sankyo 4568:JP Y 1272053M 19255M
Esperion Therapeutics ESPR:US $ -269394000 173.26M
Exelixis EXEL:US $ 1911.19M 32.07M
Gilead Sciences GILD:US $ 18964M 762M
Glaxosmithkline GSK:US $ 14865M 278M
Intercept Pharmaceuticals ICPT:US $ -200M 33.15M
Macrogenics MGNX:US $ 350.53M 54.65M
Mirati Therapeutics MRTX:US $ 1259.41M 101.38M
Moderna Inc MRNA:US 3.84B 1.28B
Novartis NOVN:VX SF 50523M 6075M
Ptc Therapeutics PTCT:US $ 292.58M 189.41M
Puma Biotechnology PBYI:US $ 16.44M 22.39M
Regeneron Pharmaceuticals REGN:US $ 11977M 951.7M
Sangamo Biosciences SGMO:US $ 470.36M 27.88M
Sarepta Therapeutics SRPT:US $ 535.45M 226.31M
Seattle Genetics SGEN:US $ 3424.62M 63.48M
Spectrum Pharmaceuticals SPPI:US $ 122.44M 11.8M
Takeda 4502:JP Y 5173037M 537684M
Tg Therapeutics TGTX:US $ 445.28M 74.06M
Ultragenyx Pharmaceutical RARE:US $ 1054.58M 99.79M
Vanda Pharmaceuticals VNDA:US $ 467.63M 14.36M
Vertex Pharmaceuticals VRTX:US $ 8980.25M 293.44M
YTE INCY:US $ 2727.84M 116.58M